Benefits versus profits: has the orphan drug act gone too far?

Garber, A M

Benefits versus profits: has the orphan drug act gone too far? [electronic resource] - PharmacoEconomics Feb 1994 - 88-92 p. digital

Publication Type: Editorial; Research Support, Non-U.S. Gov't

1170-7690

10.2165/00019053-199405020-00002 doi


Drug Costs
Humans
Orphan Drug Production--economics
United States